Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Elicio Therapeutics (ELTX) Revenue (2020 - 2022)

Elicio Therapeutics posted quarterly Revenue of $653000.0 for Q2 2022, up 20.93% year-on-year from $540000.0 in Q2 2021, and down 60.38% on a QoQ basis from $1.6 million in Q1 2022.

Elicio Therapeutics (ELTX) has 3 years of Revenue data on file, last reported at $653000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Revenue rose 20.93% year-over-year to $653000.0; the trailing twelve-month figure through Mar 2023 stood at $653000.0 (down 97.73% YoY), and the FY2022 full-year result was $2.3 million, down 91.63% from the prior year.
  • Revenue for Q2 2022 stood at $653000.0, down from $1.6 million in the prior quarter.
  • Across five years, Revenue topped out at $25.1 million in Q4 2021 and bottomed at -$2.2 million in Q4 2020.
  • The 3-year median for Revenue is $729000.0 (2020), against an average of $3.2 million.
  • Peak annual rise in Revenue reached 1228.14% in 2021, while the deepest fall reached 25.93% in 2021.
  • A 3-year view of Revenue shows it stood at -$2.2 million in 2020, then soared by 1228.14% to $25.1 million in 2021, then sank by 97.4% to $653000.0 in 2022.
  • The last three Revenue figures came in at $653000.0 (Q2 2022), $1.6 million (Q1 2022), and $25.1 million (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Elicio Therapeutics 217.63 Mn 202.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 653,000.00
Mar 31, 2022 1.65 Mn
Dec 31, 2021 25.14 Mn
Sep 30, 2021 1.46 Mn
Jun 30, 2021 540,000.00
Mar 31, 2021 371,000.00
Dec 31, 2020 -2.23 Mn
Sep 30, 2020 827,000.00
Jun 30, 2020 729,000.00